Evidence map›Paper›PMID 41271832›Full record

ArticleScientific reports2025

Vitamin D3 ameliorates inflammation and autonomic dysfunction in a rat model of reflux esophagitis via modulation of IL-6 and TNF-α.

Sally M Abdelmonem, Amr Elkelish, Wael A Hassan, Mohammed M Ahmed, Komla Mawunyo Dossouvi, Mai Adawi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sally M AbdelmonemMedical Physiology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Amr ElkelishBiology Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), P.O. Box, 1690950, 11623, Riyadh, Saudi Arabia.
Wael A HassanClinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Mohammed M AhmedBiology Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), P.O. Box, 1690950, 11623, Riyadh, Saudi Arabia.
Komla Mawunyo DossouviDepartment of Microbiology, Global Health Research Institute, Lomé, Togo. dossouvikomlamawunyo@gmail.com.
Mai AdawiMedical Physiology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastroesophageal reflux disease (GERD) and its manifestation as reflux esophagitis (RE) involves mucosal inflammation and autonomic dysfunction. Vitamin D3 deficiency is increasingly implicated in gastrointestinal inflammation and immune imbalance. This study investigated the therapeutic and prophylactic effects of 1,25-dihydroxyvitamin D3 on esophageal inflammation and autonomic nervous system disruption in a non-surgical rat model of RE. RE was induced via intermittent fasting and refeeding. Rats received either no treatment, prophylactic vitamin D3 (1250 IU/day pre- and post-induction), or therapeutic vitamin D3 (post-induction only). We assessed esophageal histopathology, immunohistochemical expression of tumor necrosis factor α (TNF-α) and transforming growth factor β (TGF-β), serum interleukin 6 (IL-6) levels via ELISA, and heart rate variability (HRV) indices. RE rats exhibited characteristic mucosal damage, elevated IL-6 and TNF-α expression, and impaired HRV (reduced standard deviation of normal to normal intervals (SDNN), High frequency (HF); increased low frequency/high frequency ratio (LF/HF)). Vitamin D3 supplementation significantly reversed these alterations. Prophylactic administration showed superior efficacy in preserving mucosal integrity and autonomic function compared to therapeutic intervention. Notably, TNF-α expression was abolished and IL-6 was significantly reduced. 1,25-dihydroxyvitamin D3 exerts protective and therapeutic effects in RE through suppression of inflammatory cytokines and restoration of autonomic balance. These findings support its potential as a neuroimmune modulator in esophageal inflammatory diseases. Heart rate variability (HRV) was assessed as an autonomic marker, and correlations with cytokine levels were explored. Scale bars and schematic workflow diagrams were included for clarity. A Limitations section was added to acknowledge constraints such as absence of a DMSO control.

Indexed as

CholecalciferolEsophagitis, PepticInflammationInterleukin-6Tumor Necrosis Factor-alphaAnimalsAutonomic Nervous SystemDisease Models, AnimalHeart RateMaleRatsRats, Sprague-DawleyCholecalciferolIl6 protein, ratInterleukin-6Tumor Necrosis Factor-alphaAutonomic dysfunctionHeart rate variabilityIL-6InflammationReflux esophagitisTNF-αVitamin D3

Identifiers

PMID41271832
PMCPMC12638938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.